Work

Abstract 506: Wnt/â-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer

Year: 2019

Type: conference-abstract

Source: Immunology

DOI: 10.1158/1538-7445.sabcs18-506

Authors: Caroline Phillips, Inder Bhamra, Catherine Eagle, Alicia Edmenson Cook, Cliff Jones, Simon Woodcock

Institution: Redx Pharma (United Kingdom)

Language: English

Topic: Wnt/β-catenin signaling in development and cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4240636458

Cites:

Cited by:

Related to: 10